Methodological approaches and insights on protein aggregation in biological systems
暂无分享,去创建一个
[1] M. Mann,et al. Widespread Proteome Remodeling and Aggregation in Aging C. elegans , 2017, Cell.
[2] E. O’Brien,et al. Extracellular Release and Signaling by Heat Shock Protein 27: Role in Modifying Vascular Inflammation , 2016, Front. Immunol..
[3] K. Otsu,et al. Autophagy during cardiac remodeling. , 2016, Journal of molecular and cellular cardiology.
[4] J. Mehta,et al. Age- and Hypertension-Associated Protein Aggregates in Mouse Heart Have Similar Proteomic Profiles , 2016, Hypertension.
[5] R. Morimoto,et al. The biology of proteostasis in aging and disease. , 2015, Annual review of biochemistry.
[6] Xianlin Sun,et al. Doxycycline ameliorates aggregation of collagen and atrial natriuretic peptide in murine post-infarction heart. , 2015, European journal of pharmacology.
[7] Rafael Zambrano,et al. AGGRESCAN3D (A3D): server for prediction of aggregation properties of protein structures , 2015, Nucleic Acids Res..
[8] Dmitri I. Svergun,et al. The architecture of amyloid-like peptide fibrils revealed by X-ray scattering, diffraction and electron microscopy , 2015, Acta crystallographica. Section D, Biological crystallography.
[9] Jie Sui,et al. Cullin Family Proteins and Tumorigenesis: Genetic Association and Molecular Mechanisms , 2015, Journal of Cancer.
[10] T. McKinsey,et al. Tubulin hyperacetylation is adaptive in cardiac proteotoxicity by promoting autophagy , 2014, Proceedings of the National Academy of Sciences.
[11] I. Kaltashov,et al. Characterization of small protein aggregates and oligomers using size exclusion chromatography with online detection by native electrospray ionization mass spectrometry. , 2014, Analytical chemistry.
[12] M. Sharon,et al. Regulating the 20S Proteasome Ubiquitin-Independent Degradation Pathway , 2014, Biomolecules.
[13] G. Agnetti,et al. Protein post‐translational modifications and misfolding: New concepts in heart failure , 2014, Proteomics. Clinical applications.
[14] J. Hoseki,et al. Mitochondrial impairment triggers cytosolic oxidative stress and cell death following proteasome inhibition , 2014, Scientific Reports.
[15] M. Heneka,et al. Truncated and modified amyloid-beta species , 2014, Alzheimer's Research & Therapy.
[16] M. Michalak,et al. The many functions of the endoplasmic reticulum chaperones and folding enzymes , 2014, IUBMB life.
[17] D. Kass,et al. Desmin modifications associate with amyloid-like oligomers deposition in heart failure. , 2014, Cardiovascular research.
[18] A. Rosenberg,et al. New FDA Draft Guidance on Immunogenicity , 2014, The AAPS Journal.
[19] A. Simm,et al. Role of advanced glycation end products in cellular signaling , 2014, Redox biology.
[20] Chadwick M. Hales,et al. Pharmacologic Inhibition of ROCK2 Suppresses Amyloid-β Production in an Alzheimer's Disease Mouse Model , 2013, The Journal of Neuroscience.
[21] B. Raman,et al. The Extracellular Chaperone Haptoglobin Prevents Serum Fatty Acid-promoted Amyloid Fibril Formation of β2-Microglobulin, Resistance to Lysosomal Degradation, and Cytotoxicity , 2013, The Journal of Biological Chemistry.
[22] Charles D. Schwieters,et al. Molecular Structure of β-Amyloid Fibrils in Alzheimer’s Disease Brain Tissue , 2013, Cell.
[23] Casey Cook,et al. Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance , 2013, Human molecular genetics.
[24] Michael A Weiss,et al. Diabetes mellitus due to the toxic misfolding of proinsulin variants , 2013, FEBS letters.
[25] L. Xue,et al. Evaluation of Pre-existing Antibody Presence as a Risk Factor for Posttreatment Anti-drug Antibody Induction: Analysis of Human Clinical Study Data for Multiple Biotherapeutics , 2013, The AAPS Journal.
[26] S. Ausar,et al. Forced degradation studies: an essential tool for the formulation development of vaccines , 2013 .
[27] V. Lee,et al. The microtubule-associated tau protein has intrinsic acetyltransferase activity , 2013, Nature Structural &Molecular Biology.
[28] Cam Patterson,et al. Proteotoxicity and cardiac dysfunction--Alzheimer's disease of the heart? , 2013, The New England journal of medicine.
[29] Xuejun Wang,et al. Posttranslational modification and quality control. , 2013, Circulation research.
[30] C. MacPhee,et al. Mass spectrometry methods for intrinsically disordered proteins. , 2013, The Analyst.
[31] V. Andrisano,et al. Disclosure of a fundamental clue for the elucidation of the myricetin mechanism of action as amyloid aggregation inhibitor by mass spectrometry , 2012, Electrophoresis.
[32] S. Finkbeiner,et al. Protein aggregates in Huntington's disease , 2012, Experimental Neurology.
[33] Nobel C. Zong,et al. Post-translational modification of cardiac proteasomes: functional delineation enabled by proteomics. , 2012, American journal of physiology. Heart and circulatory physiology.
[34] A. Levey,et al. Coaggregation of RNA-Binding Proteins in a Model of TDP-43 Proteinopathy with Selective RGG Motif Methylation and a Role for RRM1 Ubiquitination , 2012, PloS one.
[35] K. Chung,et al. Neddylation positively regulates the ubiquitin E3 ligase activity of parkin , 2012, Journal of neuroscience research.
[36] J. Trojanowski,et al. Redox signalling directly regulates TDP‐43 via cysteine oxidation and disulphide cross‐linking , 2012, The EMBO journal.
[37] Bradford W Gibson,et al. Proteomic analysis of age-dependent changes in protein solubility identifies genes that modulate lifespan , 2012, Aging cell.
[38] I. Kaltashov,et al. Evaluation of electrospray ionization mass spectrometry as a tool for characterization of small soluble protein aggregates. , 2012, Analytical chemistry.
[39] S. Joshi,et al. Investigation of protein conformational stability employing a multimodal spectrometer. , 2011, Analytical chemistry.
[40] M. Ohno,et al. Therapeutic effects of remediating autophagy failure in a mouse model of Alzheimer disease by enhancing lysosomal proteolysis , 2011, Autophagy.
[41] C. Behl. BAG3 and friends: Co-chaperones in selective autophagy during aging and disease , 2011, Autophagy.
[42] Thomas Hartmann,et al. The cullin protein family , 2011, Genome Biology.
[43] U. Wolfrum,et al. BAG3 mediates chaperone‐based aggresome‐targeting and selective autophagy of misfolded proteins , 2011, EMBO reports.
[44] Jinbao Liu,et al. Perturbation of Cullin Deneddylation via Conditional Csn8 Ablation Impairs the Ubiquitin–Proteasome System and Causes Cardiomyocyte Necrosis and Dilated Cardiomyopathy in Mice , 2011, Circulation research.
[45] A. Boyle,et al. The aging heart and post-infarction left ventricular remodeling. , 2011, Journal of the American College of Cardiology.
[46] I. Kaltashov,et al. Impact of oxidation on protein therapeutics: Conformational dynamics of intact and oxidized acid‐β‐glucocerebrosidase at near‐physiological pH , 2010, Protein science : a publication of the Protein Society.
[47] N. Perrimon,et al. FOXO/4E-BP Signaling in Drosophila Muscles Regulates Organism-wide Proteostasis during Aging , 2010, Cell.
[48] Bernd Bukau,et al. Cellular strategies for controlling protein aggregation , 2010, Nature Reviews Molecular Cell Biology.
[49] P. Ping,et al. Differential Regulation of Proteasome Function in Isoproterenol-Induced Cardiac Hypertrophy , 2010, Circulation research.
[50] P. Palumaa,et al. Label-free high-throughput screening assay for inhibitors of Alzheimer's amyloid-β peptide aggregation based on MALDI MS. , 2010, Analytical chemistry.
[51] Alma L. Burlingame,et al. Widespread Protein Aggregation as an Inherent Part of Aging in C. elegans , 2010, PLoS biology.
[52] M. Sukumar,et al. Quantification and characterization of subvisible proteinaceous particles in opalescent mAb formulations using micro-flow imaging. , 2010, Journal of pharmaceutical sciences.
[53] C. Holmberg,et al. A photoconvertible reporter of the ubiquitin-proteasome system in vivo , 2010, Nature Methods.
[54] F. Pagani,et al. Ubiquitin Proteasome Dysfunction in Human Hypertrophic and Dilated Cardiomyopathies , 2010, Circulation.
[55] M. Sheng,et al. Autophosphorylated CaMKIIα Acts as a Scaffold to Recruit Proteasomes to Dendritic Spines , 2010, Cell.
[56] C. Behl,et al. HSF1-Controlled and Age-Associated Chaperone Capacity in Neurons and Muscle Cells of C. elegans , 2010, PloS one.
[57] D. Klionsky,et al. Regulation mechanisms and signaling pathways of autophagy. , 2009, Annual review of genetics.
[58] Subhash D. Katewa,et al. 4E-BP Extends Lifespan upon Dietary Restriction by Enhancing Mitochondrial Activity in Drosophila , 2009, Cell.
[59] Chi-Ting Huang,et al. Quantitation of protein particles in parenteral solutions using micro-flow imaging. , 2009, Journal of pharmaceutical sciences.
[60] Elizabeth A Miller,et al. Collapse of proteostasis represents an early molecular event in Caenorhabditis elegans aging , 2009, Proceedings of the National Academy of Sciences.
[61] Xin Lin,et al. The E3 Ligase TRAF6 Regulates Akt Ubiquitination and Activation , 2009, Science.
[62] C. Maas,et al. Physiological responses to protein aggregates: Fibrinolysis, coagulation and inflammation (new roles for old factors) , 2009, FEBS letters.
[63] W. Engel,et al. Inclusion Body Myositis: A Degenerative Muscle Disease Associated with Intra‐Muscle Fiber Multi‐Protein Aggregates, Proteasome Inhibition, Endoplasmic Reticulum Stress and Decreased Lysosomal Degradation , 2009, Brain pathology.
[64] J. Philo,et al. A critical review of methods for size characterization of non-particulate protein aggregates. , 2009, Current pharmaceutical biotechnology.
[65] Christopher M. Dobson,et al. Experimental characterization of disordered and ordered aggregates populated during the process of amyloid fibril formation , 2009, Proceedings of the National Academy of Sciences.
[66] K. Davies,et al. Mitochondrial Lon protease is a human stress protein. , 2009, Free radical biology & medicine.
[67] Shoji Takada,et al. Bimodal protein solubility distribution revealed by an aggregation analysis of the entire ensemble of Escherichia coli proteins , 2009, Proceedings of the National Academy of Sciences.
[68] Pornpimol Charoentong,et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks , 2009, Bioinform..
[69] N. Durany,et al. Oxidative stress in Alzheimer disease , 2009, Cell adhesion & migration.
[70] Masayuki Miura,et al. Genetic Evidence Linking Age-Dependent Attenuation of the 26S Proteasome with the Aging Process , 2008, Molecular and Cellular Biology.
[71] F. Regnier,et al. Protein:protein aggregation induced by protein oxidation. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[72] C. Maas,et al. Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation. , 2008, The Journal of clinical investigation.
[73] Tommer Ravid,et al. Diversity of degradation signals in the ubiquitin–proteasome system , 2008, Nature Reviews Molecular Cell Biology.
[74] Daniel Kaganovich,et al. Misfolded proteins partition between two distinct quality control compartments , 2008, Nature.
[75] Liming Zhao,et al. Simultaneous monitoring of peptide aggregate distributions, structure, and kinetics using amide hydrogen exchange: Application to Aβ(1‐40) fibrillogenesis , 2008, Biotechnology and bioengineering.
[76] Janet L. Johnstone,et al. Intracellular Protein Aggregation Is a Proximal Trigger of Cardiomyocyte Autophagy , 2008, Circulation.
[77] J. Landry,et al. HspB8 and Bag3: A new chaperone complex targeting misfolded proteins to macroautophagy , 2008, Autophagy.
[78] C. Maas,et al. Identification of fibronectin type I domains as amyloid-binding modules on tissue-type plasminogen activator and three homologs , 2008, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[79] A. Cavalli,et al. Insight Into the Kinetic of Amyloid β (1–42) Peptide Self‐Aggregation: Elucidation of Inhibitors’ Mechanism of Action , 2007, Chembiochem : a European journal of chemical biology.
[80] A. Ariza,et al. Protein Aggregation Mechanisms in Synucleinopathies: Commonalities and Differences , 2007, Journal of neuropathology and experimental neurology.
[81] G. Farr,et al. Two families of chaperonin: physiology and mechanism. , 2007, Annual review of cell and developmental biology.
[82] R. Palmiter,et al. Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via binding to HDAC6 , 2007, The Journal of cell biology.
[83] T. Yao,et al. HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates. , 2007, Genes & development.
[84] L A M van der Wielen,et al. Surfactant-aided size-exclusion chromatography for the purification of immunoglobulin G. , 2007, Journal of chromatography. A.
[85] L. Papa,et al. Reactive oxygen species induced by proteasome inhibition in neuronal cells mediate mitochondrial dysfunction and a caspase-independent cell death , 2007, Apoptosis.
[86] R. Kayed,et al. Small Molecule Inhibitors of Aggregation Indicate That Amyloid β Oligomerization and Fibrillization Pathways Are Independent and Distinct* , 2007, Journal of Biological Chemistry.
[87] W. Surewicz,et al. β-Sheet core of human prion protein amyloid fibrils as determined by hydrogen/deuterium exchange , 2007, Proceedings of the National Academy of Sciences.
[88] N. Rosen,et al. An acetylation site in the middle domain of Hsp90 regulates chaperone function. , 2007, Molecular cell.
[89] I. Rubinstein,et al. PEGylated phospholipid nanomicelles interact with β-amyloid(1–42) and mitigate its β-sheet formation, aggregation and neurotoxicity in vitro , 2006, Peptides.
[90] Brian J Bacskai,et al. Plaque-Derived Oxidative Stress Mediates Distorted Neurite Trajectories in the Alzheimer Mouse Model , 2006, Journal of neuropathology and experimental neurology.
[91] D. Rubinsztein,et al. The roles of intracellular protein-degradation pathways in neurodegeneration , 2006, Nature.
[92] Bruce L. Miller,et al. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.
[93] D I Svergun,et al. The impact of protein characterization in structural proteomics , 2006, Acta crystallographica. Section D, Biological crystallography.
[94] J. Scholz,et al. Interaction of the amyloid precursor like protein 1 with the alpha2A-adrenergic receptor increases agonist-mediated inhibition of adenylate cyclase. , 2006, Cellular signalling.
[95] Ehud Cohen,et al. Opposing Activities Protect Against Age-Onset Proteotoxicity , 2006, Science.
[96] A. Rosenberg,et al. Effects of protein aggregates: An immunologic perspective , 2006, The AAPS Journal.
[97] L. Chao,et al. The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction , 2006, Biological chemistry.
[98] J. Busciglio,et al. Different Conformations of Amyloid β Induce Neurotoxicity by Distinct Mechanisms in Human Cortical Neurons , 2006, The Journal of Neuroscience.
[99] J. Weissman,et al. Molecular Chaperones and Protein Quality Control , 2006, Cell.
[100] A. Bonvin,et al. The α‐to‐β Conformational Transition of Alzheimer's Aβ‐(1–42) Peptide in Aqueous Media is Reversible: A Step by Step Conformational Analysis Suggests the Location of β Conformation Seeding , 2006 .
[101] Bin Chen,et al. The HSP90 family of genes in the human genome: insights into their divergence and evolution. , 2005, Genomics.
[102] Sheena E Radford,et al. The Yin and Yang of protein folding , 2005, The FEBS journal.
[103] R. Abraham,et al. Genotoxic stress targets human Chk1 for degradation by the ubiquitin-proteasome pathway. , 2005, Molecular cell.
[104] T. Sommer,et al. ERAD: the long road to destruction , 2005, Nature Cell Biology.
[105] S. Ferré,et al. Amazing stability of the arginine-phosphate electrostatic interaction. , 2005, Journal of proteome research.
[106] T. Dawson,et al. Response to Comment on "S-Nitrosylation of Parkin Regulates Ubiquitination and Compromises Parkin's Protective Function" , 2005, Science.
[107] J. Brodsky,et al. Use of yeast as a model system to investigate protein conformational diseases , 2005, Molecular biotechnology.
[108] Minoru Yoshida,et al. HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. , 2005, Molecular cell.
[109] Thomas Nyström,et al. Role of oxidative carbonylation in protein quality control and senescence , 2005, The EMBO journal.
[110] C. R. Middaugh,et al. Silicone oil induced aggregation of proteins. , 2005, Journal of pharmaceutical sciences.
[111] M. Manning,et al. Heterogeneous nucleation-controlled particulate formation of recombinant human platelet-activating factor acetylhydrolase in pharmaceutical formulation. , 2005, Journal of pharmaceutical sciences.
[112] J. Hoh,et al. Amyloid-β Protofibrils Differ from Amyloid-β Aggregates Induced in Dilute Hexafluoroisopropanol in Stability and Morphology* , 2005, Journal of Biological Chemistry.
[113] S. Yokoyama,et al. Phosphorylation analysis of 90 kDa heat shock protein within the cytosolic arylhydrocarbon receptor complex. , 2004, Biochemistry.
[114] V. Uversky,et al. The effect of macromolecular crowding on protein aggregation and amyloid fibril formation , 2004, Journal of molecular recognition : JMR.
[115] I. Teraoka. Calibration of retention volume in size exclusion chromatography by hydrodynamic radius , 2004 .
[116] Huub Schellekens,et al. Structure-Immunogenicity Relationships of Therapeutic Proteins , 2004, Pharmaceutical Research.
[117] C. Dobson. Protein folding and misfolding , 2003, Nature.
[118] E. Forest,et al. Use of different proteases working in acidic conditions to improve sequence coverage and resolution in hydrogen/deuterium exchange of large proteins. , 2003, Rapid communications in mass spectrometry : RCM.
[119] D. Geschwind. Tau Phosphorylation, Tangles, and Neurodegeneration The Chicken or the Egg? , 2003, Neuron.
[120] V. Andrisano,et al. beta-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies. , 2003, Biochemical pharmacology.
[121] J. Trojanowski,et al. Phosphorylated α-Synuclein Is Ubiquitinated in α-Synucleinopathy Lesions* , 2002, The Journal of Biological Chemistry.
[122] D. Teplow,et al. Kinetic Studies of Amyloid β-Protein Fibril Assembly , 2002, The Journal of Biological Chemistry.
[123] Richard I. Morimoto,et al. The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[124] E. Masliah,et al. α-Synuclein is phosphorylated in synucleinopathy lesions , 2002, Nature Cell Biology.
[125] R. Lal,et al. Amyloid β protein forms ion channels: implications for Alzheimer's disease pathophysiology , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[126] B. Friguet,et al. Oxidative Modification and Inactivation of the Proteasome during Coronary Occlusion/Reperfusion* , 2001, The Journal of Biological Chemistry.
[127] N. C. Price,et al. The use of circular dichroism in the investigation of protein structure and function. , 2000, Current protein & peptide science.
[128] P. Fraser,et al. Alternate aggregation pathways of the Alzheimer beta-amyloid peptide. An in vitro model of preamyloid. , 2000, The Journal of biological chemistry.
[129] Hans-Georg Rammensee,et al. gp96—The immune system's Swiss army knife , 2000, Nature Immunology.
[130] J. Schenck. Safety of Strong, Static Magnetic Fields , 2000, Journal of magnetic resonance imaging : JMRI.
[131] D. Walsh,et al. An improved method of preparing the amyloid β-protein for fibrillogenesis and neurotoxicity experiments , 2000, Neurobiology of Aging.
[132] E. Stadtman,et al. Protein Oxidation , 2000, Annals of the New York Academy of Sciences.
[133] E. Shacter. QUANTIFICATION AND SIGNIFICANCE OF PROTEIN OXIDATION IN BIOLOGICAL SAMPLES* , 2000, Drug metabolism reviews.
[134] R. Kopito,et al. Aggresomes: A Cellular Response to Misfolded Proteins , 1998, The Journal of cell biology.
[135] P. Lansbury,et al. Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein. , 1997, Chemistry & biology.
[136] C. Yu,et al. Acetonitrile-induced conformational transitions in poly-L-lysine. , 1997, International journal of biological macromolecules.
[137] J. Riordan,et al. Multiple proteolytic systems, including the proteasome, contribute to CFTR processing , 1995, Cell.
[138] B. Friguet,et al. Susceptibility of glucose-6-phosphate dehydrogenase modified by 4-hydroxy-2-nonenal and metal-catalyzed oxidation to proteolysis by the multicatalytic protease. , 1994, Archives of biochemistry and biophysics.
[139] Zhongqi Zhang,et al. Determination of amide hydrogen exchange by mass spectrometry: A new tool for protein structure elucidation , 1993, Protein science : a publication of the Protein Society.
[140] C. Masters,et al. Mechanisms of Amyloid Deposition in Alzheimer's Disease a , 1991, Annals of the New York Academy of Sciences.
[141] Sílvia Bronsoms,et al. Applications of mass spectrometry to the study of protein aggregation. , 2015, Methods in molecular biology.
[142] F. Fieschi,et al. Investigating alternative acidic proteases for H/D exchange coupled to mass spectrometry: Plasmepsin 2 but not plasmepsin 4 is active under quenching conditions , 2010, Journal of the American Society for Mass Spectrometry.
[143] A. Giuliani,et al. Bmc Structural Biology a Knowledge-based Structure-discriminating Function That Requires Only Main-chain Atom Coordinates , 2008 .
[144] Neil E. Jacobsen,et al. NMR spectroscopy explained : simplified theory, applications and examples for organic chemistry and structural biology , 2007 .
[145] A. Bonvin,et al. The alpha-to-beta conformational transition of Alzheimer's Abeta-(1-42) peptide in aqueous media is reversible: a step by step conformational analysis suggests the location of beta conformation seeding. , 2006, Chembiochem : a European journal of chemical biology.
[146] C. Soto,et al. Amyloid inhibitors and beta-sheet breakers. , 2005, Sub-cellular biochemistry.
[147] J. Hoh,et al. Amyloid-beta protofibrils differ from amyloid-beta aggregates induced in dilute hexafluoroisopropanol in stability and morphology. , 2005, The Journal of biological chemistry.
[148] C. Soto,et al. Beta-sheet breakers for Alzheimer's disease therapy. , 2004, Current drug targets.
[149] G. Münch,et al. Advanced glycation endproducts cause lipid peroxidation in the human neuronal cell line SH-SY5Y. , 2003, Journal of Alzheimer's disease : JAD.
[150] D. Teplow,et al. Kinetic studies of amyloid beta-protein fibril assembly. Differential effects of alpha-helix stabilization. , 2002, The Journal of biological chemistry.
[151] E. Voest,et al. Tissue-type plasminogen activator is a multiligand cross-beta structure receptor. , 2002, Current biology : CB.
[152] J. Trojanowski,et al. Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions. , 2002, The Journal of biological chemistry.